Patients with chemorefractory metastatic colorectal cancer derive no overall survival benefit from giving anti-EGFR ...

Government agreement with IVF drug manufacturer drops price in exchange for tariff reductions, expedited FDA approval ...

Among 16 patients with this difficult-to-treat tumor "with few treatment options," the confirmed overall response rate (ORR) ...

President Donald Trump on Friday announced a deal with pharmaceutical company Merck and its U.S. subsidiary, EMD Serono, to ...

Median disease-free survival (DFS) increased from 4.8 months with placebo to 9.9 months with adjuvant atezolizumab (Tecentriq ...

Fertility drugmaker EMD Serono, the U.S. arm of Merck KGaA, will offer its in vitro fertilization (IVF) treatments at a sharp discount on the government's DTC platform TrumpRx.

As a newly christened manufacturing facility comes online in one part of Ireland, Merck KGaA plans to turn out the lights at ...

The Trump administration struck a deal with EMD Serono, the health care business of Merck KGaA in the United States and ...

Trump, in an effort to lower drug costs for U.S. patients who pay far more than in other wealthy nations, has so far struck ...

EMD Serono's agreement with the US government aims to expand IVF therapy access for 10 million women, offering significant ...

Progyny (PGNY) stock turns volatile as Wall Street weighs in on how the company will be impacted by the Trump ...

Merck will offer its complete portfolio of IVF therapies through the president’s direct-to-consumer platform, TrumpRX, and ...